Uniwersyteckie Centrum Stomatologii I Medycyny Specjalistycznej Sp. z o.o.

At Uniwersyteckie Centrum Stomatologii I Medycyny Specjalistycznej Sp. z o.o. in Poznan, cardiology research focuses on cardiovascular diseases, especially atherosclerotic cardiovascular disease and elevated lipoprotein(a). These studies are designed to evaluate whether new treatments can lower major heart-related risks and improve long-term outcomes.

• Cardiovascular disease and elevated lipoprotein(a)
• Preventing coronary heart disease events and related complications
• Testing therapies that may reduce heart attack and revascularization risk

This area reflects a strong interest in improving prevention and treatment strategies for people at high cardiovascular risk.

The site also supports research in nutritional and metabolic diseases and metabolism, with a major emphasis on chronic kidney disease, high proteinuria, obesity, and metabolic dysfunction-associated steatotic liver disease. The trials are mainly aimed at slowing disease progression, protecting kidney function, and improving overall metabolic health.

• Chronic kidney disease with hypertension or high proteinuria
• Obesity and overweight linked to metabolic disease
• Metabolic dysfunction-associated steatotic liver disease

These studies explore whether newer treatment combinations can better preserve kidney function and support broader cardiometabolic care.

A substantial part of the research portfolio covers digestive system diseases and immune system diseases, especially Crohn’s disease and ulcerative colitis. The trials are focused on improving symptom control, achieving remission, and strengthening long-term disease management for patients with inflammatory bowel disease.

• Crohn’s disease, including moderately to severely active forms
• Ulcerative colitis and treatment maintenance
• Evaluating combinations and newer therapies for better clinical outcomes

This research area highlights efforts to refine treatment effectiveness while also addressing quality of life in chronic intestinal inflammation.

The site participates in studies of hormonal diseases and related autoimmune conditions, including Graves’ disease, thyroid eye disease, and classic congenital adrenal hyperplasia. These trials are designed to assess whether emerging therapies can better control hormone imbalance, reduce disease activity, and support more stable long-term management.

• Thyroid eye disease and eye-related autoimmune inflammation
• Graves’ disease and maintenance of normal thyroid function
• Congenital adrenal hyperplasia and adrenal hormone control

This therapeutic area combines endocrine care with autoimmune research, reflecting a broad effort to improve outcomes in complex hormone-related disorders.

Research at this hospital/clinic also includes type 1 diabetes and related metabolic conditions. The main goal is to evaluate treatment options that may improve glycaemic control and make diabetes management more effective and practical for patients living with long-term metabolic disease.

• Type 1 diabetes and blood sugar control
• Supporting better day-to-day metabolic management
• Comparing new approaches with established insulin-based care

These studies add to the site’s wider focus on metabolism and chronic disease care.